ASO Author Reflections: Low-Volume Sentinel Node Disease after Neoadjuvant Chemotherapy Is Still an Indication for Axillary Dissection

Ähnliche Einträge

• Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
  von: Moo, Tracy-Ann, et al.
  Veröffentlicht: (2018)
• Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate”
  von: Moo, Tracy-Ann, et al.
  Veröffentlicht: (2020)
• ASO Author Reflections: Discharge Without Opioids After Lumpectomy with Sentinel Node Biopsy Should Be the Norm, Not the Exception
  von: Moo, Tracy-Ann, et al.
  Veröffentlicht: (2020)
• ASO Author Reflections: A Negative Axillary Clinical Exam Adequately Identifies Clinically Node-Positive Patients Who Downstage After NAC and Are Candidates for SLNB
  von: Moo, Tracy-Ann, et al.
  Veröffentlicht: (2019)
• ASO Author Reflections: The Impact of Neoadjuvant Chemotherapy on Exploration of Fertility Preservation
  von: Crown, Angelena, et al.
  Veröffentlicht: (2020)